Closed tender · Germany · Contract notice

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Elafibranor (OBO), ATC A05AX06 für die Zeit 01.12.2024 - 30.11.2026

In EnglishConclusion of a non-exclusive discount agreement under § 130a para. 8 SGB V for the active ingredient Elafibranor (OBO), ATC A05AX06 for the period 01.12.2024 - 30.11.2026

DAK-Gesundheit

DAK-Gesundheit in Germany invited bids for “Conclusion of a non-exclusive discount agreement under § 130a para. 8 SGB V for the active ingredient Elafibranor (OBO), ATC A05AX06 for the period…”. Bids closed on 5 October 2026.

The work

Non-exclusive discount agreement for Elafibranor (ATC A05AX06) from 01.12.2024 to 30.11.2026.

Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences